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(Director Prof. Dr. Ersm Ko~oo) 
Although the therapy of malignant osteogenic sarcoma is clinically regarded to be 
very difficult, there has been only a litle research reported in this field, and the effect 
of anticancerous agents has remained unclarified. One of the reasons is the difficulty of 
developing experimental bone tumors. 
The author was able to implant ¥V ALKER carcinosarcoma into the tibial bone marrow 
of the rat, and produce a bone tumor graft which resembled human osteogenic sarcoma 
and which seemed to fulfil the various requirements of an experimental tumor. 
The nature of this bone tumor and its behavior under anticancer therapy were ob-
served roentgenographically, histologically and macroscopically. 
1. This experimental bone tumor had a 73.3% successful transplantation rate, 24.3 
days mean survival time, and 68%, 48% and 3% metastasis to the lung, lymph nodes 
and kidney, respectively, and was undetectable in the other organs. Metastasis to the lung 
seems to be induced by the embolism of tumor cels which are carried there by the 
blood stream just after transplantation, and which continue to be spread gradually via the 
blood as the local tumor expands. It is very similar to human osteogenic sarcoma in that 
it promotes formation of trabeculum and cortex in the transplanted area, and a marked 
spicule-like osteogenesis, and that some of the tumor cells appear in the newly-formed 
bone with shapes of atypical osteocytes and osteoblasts. 
2. This experimental bone tumor is quite sensiti日 toanticancerous agents, specifi-
cally clasmatosis of tumor cels, and the occurrence of giant cells with the pyknosis and 
clasmatosis of the nucleus, and swollen cytoplasm. These changes are not detectable in 
the control group. So there is hope for the chemotherapy of human malignant osteogenic 
sarcoma, showing the prolongation of life after the so-called middle stage (the stage when 




The application of anticancerous agents lowers the rate of lung metastasis to 20～ 
40% of the control group, but the local tumor is reduced only in the few cases in which 
the periods of life is prolonged. 
The peripheral blood in the last stage shows anemia (less than three million eryth-
rocytes) and leucocytosis (more than 50,000 white blood cells) in the control group, 
while in the group receiving anticancerous agents erythrocytes are kept nearly in the 
normal range with only a slight decrease and leucocytes fluctuate a litle with a tempo-
rary decrease. 
It seems likely that the mode of application of the anticancerous agents has someth句
ing to do with their side effects, since intermittent application is more effective than con-
tinuous. The fact that intermittent use of two agents together results in marked pro-
longation of life and has an inhibitory effect on lung metastasis suggests that this method 
Ill乱ybe more usefull if the selection of anticancerous agenst and the mode of combination 
are taken into consideration. 
Local injection into the bone tumor is believed to drive the tumor cels into the 
blood, thus increasing the formation of lung metastasis. Therefore, the injection of 
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Fig. 2 初期治療群における生存率
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抗癒剤の初期投りはヤ卜Hi't'、·J i ｛.~ ；J：；との併用療法と隣同意
義的と考えられる．
移植後24時間同よ りi：射を開始し，ナイトロミンと







20 40 45 （日）30 
であった．
2) 中期投与群
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の傾向は抗j~·：；；：斉lj~与の翌日より発現し，ナイトロミン
がJえも著るしく， M‘重聞i<J.の徴を示すのに30日以上の
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第2項骨髄内投与
局所投与療法としてp 移摘後24時間目にナイトロミ



















































て認められる場合が多く p 腫， m~骨の近位端は骨の吸
収，破壊の像が著明であるが異常化骨形成の像も混在
している．大腿骨遠位端も侵喰されている像を認め
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／検索数/ 'l7Z (%) 
対照 I 36/53 68 
I 1s叫 6125 24 
Tespamm JOOCγ〉 4/9 45 
一一一
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IOQOCγ〕l 9/22 41 
Nitromm 50QCγ） 4/9 45 
250（γ） 1/9 II 
10（γ） 12/31 40 
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Tc山内11、仁川 ｜ 5(y) 5/10 50 
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2（γ〕 3/7 43 
70（γ〕 4 /12 33 
Mitomycin (' 50（γ〉 10/26 40 
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生を認める．ゃれて骨破壊の像と JI~に骨’移~形成が店l何
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より 3 実験約に或いは臨禾約に睦書誌の縮少をd灼， 著
効例では消失すら認めているがp 日ugiuraら76)（士抗癌
剤投与を中止することによって再度運療の埴大と付、重
減少を来し， そク~tii 菜？重慶死を JIぐしたと報告してい
る．木実験：こり2いても，抗i草剤投与中に彊場の縮小し
た例もあるが少な し死亡例に於いてはむしろ絶えず






































































































































































73.3 &o ， 平均生存 日！／.： ~4.3 日でF 肺p リ ンパ節3 腎に
夫々 68,48. 3 %の転移をみたが， 他臓何ーには転移形
成を証明し得ない．



















































IL. 日本癌学会記事，第20回総会， i:;,!961. 
骨髄内移植腫湯（WALKERCλRCINOARCOSMA）に及ぼす抗綴剤の影響に閲する実験的研究 227 
3) 卜部美代志，他 ：悪性感療に対する化学療法の
研究．治療＇ 42, 35, 1960. 
4) 大百万一：実験的骨肉腫発生に関する研究（第













42, 36. 1960. 
11）‘目下公平：肉腫の骨内移植について．日徴病誌，
25, 1225, 1931. 
12) 小坂順造：移植癌発育に及ぼす諸種化合物の影
響（I）アミンについて．癌， 47,386, 1956. 
13) 佐野関三，他：実験動物種療に対する制癌剤局
所滋流療法の研究と臨床応用例の検討．日本癌
学会記事p 第20回総会＇ 45; 1961. 
14) 佐藤八郎：癌悪液質は如何にして起るか．総合
臨床＇ 6, 1459, 1957. 
15) 佐藤春郎，他：リンパ行性転移の成立に関する
実験的研究．痕の臨床， 6,449. 1960. 
16) 鋤柄賢一，他：各種抗癌剤の吉田肉腫皮下属鹿
に及ぼす影響．癌， 48.417, 1957. 
17) 白羽弥；宿衛門，他： MitomycinXの臨床応用に
関する研究．癌， 49,Suppl., 18, 1958. 
18) 白羽弥右衛門，他・抗種傷性物質の動除内投与




20) 田崎勇三p 他：悪性腫場に λ＇itrogenMustard 
を使用した経験．奈良医学雑誌.4, 1. 1, 1953. 
21) 丹下一郎：吉田肉腫の関節及び骨髄内移権に関




の治療効果について．癌の臨床， 3,507, 1957. 
24) 寺中逮夫： Mitomycin仁の抗腫疹性に関する研
究.1. Mitomycin Cの抗彊湯性に関する実験的
倹討．大阪市立大学医学雑誌＇ 7, 272. 1958. 
25) H. ドルックレー（石館守三訳）：制癌制 N・7
スタード・N・寸キシド吃ぴ他アルキヰ化剤の実
験的比較実験．総合臨床＇ 6, 1506, 1957. 
26) 徳山英太郎p 他 ：悪性腫疹に対するナイトロミ
ンの動肱注射療法，実験的ならびに臨床的研究
r ；~＇.＼ l ~）. J1i/:, 47. 330, 1956. 
27) 長村重之p 他：マイトマイシン仁による白血病
の治療．治療＇ 42. 91. 1960. 
28) 中村貞次： Methyl-(bis-i1-chloroethyl）古川町－；＼－
什xide及び IsomyI-(bis－~－chloro-eth y I）唱mine-N-
oxideの悪性腫疹に対する動防〈注射療法に関す
る研究． 日外会誌， 55,385, 1955. 
29）浜口栄品他：外科領域に於ける Triethylene











ルモンの作用機転に就て．癌＇ 42, 105, 1951. 
34) 福留徹：肺臓癌のナイトロミン療法について．
癌， 44.372. 1953. 
35) 本級治，他 ．吉田肉遷移植による白血病像に






f吾＇ 47, 345, 1956. 
38) 山口 寿，他： S;irkolysineの吉田肉E重及ひ Sar-
koma 180に及ぼす影響について.i'):, 47. 366, 
19~6 . 
39）山口寿，他・ Triethylene Thiophosphoramide 





3, 176, 1952. 
42) Akashi, K. : Study on the anticancerous action 
of unsasurated seven membered structure, espe-
cially Colc'.-ine derivates. Gann. 48, 15, 1957. 
43) Anderson, W . .:. D.: Pathology (forth edition 1. 
1252, The C. V. Mr刈）＇、 Company,1961. 
44) Barberio, R., et al : Combined administration 
of Aureomycin and Nitrogen mustard.仁川cer,
6, 280, 1953. 
45) Berlin, N. I. ct al : The blood volume in 
cancer. Canじer.8. 796, 1955. 
46) Burchenal, J. H .et al : The effect of 5-Fluo・
rodexytidine, 5-Fluorodexyuridine, and related 
compound on transplanted mouse leukemia. 
Cancer Re淀arch.19. 494, 1959. 
47) Collier, F. ぐ： Carcinomaof the lung; Factors 
228 日本外科宝函第32巻第2号
、，hichinfluence five vear survival with special 
refe:-ence to blood v料開Iinvasion. Ann. Surg., 
146. 417, 1957. 
,¥8) Druckrey, H. : Che1r.otherapie des Krebs. Klin. 
¥Vschr., 33, 784, 1955. 
・19) Dutra, F. R., et al : 0、It＇＜州 re・リmainduced by 
Beryllium oxide. Am. J. Patho. 26, 197, 1950. 
50〕 Fischer,E. R. : The cytologic dtmonstration 
ancl significance of tumor cells in the mesenteric 
venous blood in patients ¥'ith colorectal carcin-
oma. Surg. Gyne. 81. Obst., 100, 102. 1955. 
51) Goldin, A., et al : Studies on the mechanism 
of action of chemotherapeutic a日刊b in cancer. 
L、ancer,5. 153, 195~. 
52) Horie, K. : Experimental •1't凹gemc sarcoma, 
hist••genかい of "'te＂貯 nicsarcoma. Gann, 5L 399, 
1960. 
53) Jane, J.刈， etal : Bery Ilium-induced osteogemc 
sarcoma in rabbits. J. B. Jメ， 36-B.543, 1954. 
54) Jonescu,P. : Cber das Vorlのmmenvon Gesch-
wul、L,eJlenin stri:imenden Blut von Tieren 11it 
Impfturr.oren. Zschr. Krebsforsch., 33, 264, 1931. 
55) Klopp, C.T.,et al Fractionated intra-arterial 
cancer chemotherap' with :vkthyl bis amine 
hydrochlo口ide,a preliminary reports.主m Surg .
132, 811, 1950. 
56) Knox, L C. :The relationship of massage to 
met‘＂t‘トト 1 malignant tumors. .c¥n Surg., 
75. 295, 1922. 
57) Law, L. ¥' .. Effect、ofcombinations of anti-
leukemic agents on an acute lymphocytic 
leukemia of mice. Cancer Re~earch, 12. 871, 
1952. 
58) Majima, S., et al : Clinical significance of tumor 
cells in the blood streem in patient with gastric 
carcinoma. Gann, 51. Suppl. 257, 1960. 
59) Marcus, H. : Krebszellen im、tromendenBlut 
下 Zschr.Krebsforsch. 16, 217, 1919. 
GO) Mc「lonald,G. ( ！.。etal、 Theproμhylactic 
treatment of malignant disea'c’with I¥ i trogen 
Mustard and Triethylenethiophosphoramide 
(Thi口 TEPλj:¥nn.吋urg.,145, 624, 1957. 
61) Moore, G. E. & Kondo, T. : Study of adjuvant 
cancer chemotherapy by model experiments. 
Surgery. 44. 199, 1958. 
62) Moore, P. R., etλI : The effect of 1-Nitroqu-
noline N-oxide on transplanted tumors. C.11iu・r 
Research, 20, 6:?8, 1960. 
63) Moore, G. E. : Clinical and experimental .-,bser-
vations of the ocurrence and fate of tumor cells 
in the blood streem. Ann. Surg., 146, 580, 
1957. 
64〕：＼akaharn,W .et al ・ Purification of Toxohor-
mone. 孔 second :;tudy on l•>xohormone, a 
characteristic toxic substance produced by ca恥er
ti川町、 Gann,41. 47, 1950. 
65) Okumura, A. Clinical experience with a new 
antibiotic, Chromomycin, in malignant tumor 
pc-1tint目 Gann,49. Suppl. 25, 1958. 
66) !'""I, E. H. & Dunlop, G. R. :Cancer cels in 
the blood stream. Am. J. Cancer, 21 I, 9, 
1934. 
67) 氏けto,H., et al: Experimental study of the 
tumor cells in circulating blood. Gann, 51, 
Suppl., 261. 1960. 
68) Satou, H., et al : Effects of Nitromin on 
cancer cells circulating in the blood. Gann, 51, 
Suppl., 262, 1960. 
69) Shapiro, D. M., and Gelhorn，λ： Combination 
of chemical compounds in experimental cancer 
therapy. Cancer Research, 11, 35, 1951. 
70）メlupiro, D. M. : Combination chemotherapy 
日ith 8-r¥z-1guanine and Sex Hormone on a 
mouse mammary carcinoma. Cancer Research, 
12, 713, 1952. 
71) 刈川、。 H.,et al : Clinical studies of Triethylene 
thi山phosphoramidein the treatment of inoperable 
cancer. l、川1仁er.8. 198. 1955. 
72) SI、ipper,H. E. : Carbamate> in the chemothe-
＂＂り円 fleukemia. V. Ub同 r、，Jtionof a po田ible
.i11tdeukemic synergism between Urethane and 
Methyl-bis （戸－chi<コrethyl)-amine.Cancer, 2, 475, 
1949. 
73) Skipper, H.E., et al': The antileukemic action 
of combinations .,f certain known antileukemic 
agents. Cancer Re>earch. 11, 109, 1951. 
74）汚tewart,H. L, etal : Transplantabl eand trans-
missible tumors of animals. 主tlasof tumor 
p:ith<>logy, Section XII Fascicle 40. 261, 1959. 
75) Stock, C. C. : Experimental cancer chemo-
therapy . '¥(h・;11ces in cancer research, Vol. IL 
425, 1臼s.1
76) Sugiura, K. c＼：・Stけck,C. C. : St11d1cヘina tumor 
spectrum. il. The effect of phosphoramides on 
the growth .,[ a v川 iety of mouse and rat 
tumors. Cancer Research, 15, 1955. 
77) Sugiura, K. : Studies in a tumor斗即t-rum.＼~ 
The effect of M 1tomycin C on the growth of 
a variety of mouse, rat and hamster tu間四・
（＼川cerResearch. 19, 438, 1959. 
78) 山収inra, K. cl:・ St< •ck, C. C. : Studie; 1 a 
tumor spectrum. Cincer, 5, 382, 1952. 
79) Tat、uoka,S . et al: Isolation, anti凹 nceract1-
vity and pharmacology of a 1刊 P anti-biotic 
Chromom、cin. C:inn, 49. Suppl., 23, 1958. 
80) U,11buchi, I ..只tudies on the intermittent 
































































骨髄内移植鍾湯（W ALKERC ARCINOSA.RCOMAJ に及ぼす抗癌剤の影響に｜鶏する実験的研究 233 
81) Usubuchi I. et al : The effect of Mitomycin 
C on the growth of a variety of rat and mouse 
tumors. Gann, 49, 209, 1958. 
82) Uchida, M. and Takagi, H. : On the antican-
cerous effect of p-Phenylene-di-phosphoric acid 
ktr<iethvlenimi<l. Gann, 48, 205, 1957. 
83) Wakasa, K. et al : Cancer cells in the bloorl 
。flung cancer p:1ticnts. Gann, 51, Suppl., 258, 
1960. 
